Type
Business expansion
Country
Czechia
Region
Moravskoslezsko; Moravskoslezsky;
Location of affected unit(s)
Opava
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

400 jobs
Number of planned job creations
Job creation
Announcement Date
18 October 2007
Employment effect (start)
Foreseen end date

Description

Ivax Pharmaceuticals (formely known as Galena), a subsidiary of the multinational pharmaceutical company Teva Pharmaceutical Industries, announced on 11 March 2008 that is to create approximately 400 new jobs in Opava with the expansion of its exisiting site. The firm currently employs over 1,100 people at its Opava plant, and the expansion will involve the construction of a new production facility at its site and an investment of USD 100 billion. The new facility will produce tablets and gelatine capsules. As of March 2008, there is no information on when employment at the new site will commence and when the new jobs will be created by. This is an update of media news released on 18 October 2007.


Sources

  • 11 March 2008: Hospod├írske noviny
  • 18 October 2007: Hospod├írske noviny

Citation

Eurofound (2007), Ivax Pharmaceuticals, Business expansion in Czechia, factsheet number 65915, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/65915.